this holds true for the following regimens : cyclophosphamide + lomustine + methotrexate ( response rates 14 % -38 % ) , hexamethylmelamine + doxorubicin + methotrexate ( 13 % -32 % ) , methotrexate + doxorubicin + cyclophosphamide + lomustine ( 13 % -24 % ) , cyclophosphamide + doxorubicin + cisplatin ( 0-36 % ) , cyclophosphamide + bleomycin + cisplatin ( 20 % ) , mitomycin c + vinblastine + cisplatin ( 26 % -33 % ) , cyclophosphamide + doxorubicin + etoposide + cisplatin ( 29 % ) and vindesine + cisplatin ( 33 % ) .
C0010583
cyclophosphamide
C0108844
cyclophosphamide